$2.85
0.103.64%
Last update: Nov 10, 5:49 PM

The average analyst price target for Sunshine Biopharma is $1,400, 49900.0% above the current price. The one analyst covering it rates it Buy.
Price Target Range — 2 Quarters
Analyst Consensus — 1 Analysts
Rating Trend — Last 9 Months